Search Results for: CytoReason

Startup investment – to 21/7/24

CTERA raised $80 million; CytoReason raised $80 million; OCON Therapeutics raised $10 million; HAGAR raised $5 million (total $25 million); Acculine raised $4.2 million; Upword raised $3 million;

Posted in Economy & Business | Leave a comment

Using AI to find cures for diseases

An interesting article explaining how Israel’s CytoReason (see here previously) is using AI and big data from the medical companies themselves to help reduce the cost and time required to bring a new remedy to market. https://nocamels.com/2024/02/using-ai-made-models-to-find-cures-for-disease/

Posted in Israel's Medical Achievements | Leave a comment

Smart partnership to find IBD treatments

Israel’s CytoReason (see here previously) is partnering France’s Sanofi to identify novel therapies to treat Inflammatory Bowel Disease (IBD). Sanofi will pay CytoReason millions of dollars to use the Israeli startup’s computational AI-discovery disease model platform. https://www.timesofisrael.com/sanofi-extends-cooperation-with-israels-cytoreason-for-bowel-disease-drug-discovery/

Posted in Israel's Medical Achievements | Leave a comment

Investment in Israeli startups to 9/10/22

OX Security raised $34 million; CytoReason raised $20 million from Pfizer; Kahun raised $8 million; LayerX Security raised $7.5 million; Onyxia raised $5 million; Anina Culinary Art raised $3.3 million; SensePass raised $3 million;

Posted in Economy & Business | Leave a comment

The first AI med-tech research institute

Israel’s Technion Institute is establishing the Zimin Institute for AI Solutions in Healthcare. Headed by Professor Shai Shen-Orr (founder of CytoReason), it will research human health and medicine, using big data and computational learning. It aims to benefit hospitals, new … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

7th partner for AI treatment discovery startup

Israel’s CytoReason (see here previously) has added SPI (part of Japanese giant Sumitomo) to its growing list of partners.  SPI will use CytoReason’s unique immune focused machine learning platform and represent CytoReason in the Japanese market – the third largest … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Swiss partner to fight bowel disease

Israel’s CytoReason (see here previously) is partnering Swiss multinational Ferring to find new treatments for patients with inflammatory bowel disease (IBD). CytoReason’s AI technology will enable the joint building of models of diseased cells on which therapies will be tested. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

So how is your health?

Another exciting webinar (see previous) from Technion UK featuring Technion Professor Shai Shen-Orr (founder of CytoReason) one of the leading Israeli researchers into the mysteries of the immune system. Also featured is Professor Ester Sager who is developing biosensors to … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Pfizer partners with Israeli AI biotech

I reported previously on Israel’s CytoReason which uses an Artificial Intelligent learning model to discover treatments related to the human immune system. CytoReason has just partnered with Pfizer – its fifth alliance with a major company. http://nocamels.com/2019/01/drug-discovery-cytoreason-pfizer/ https://docs.wixstatic.com/ugd/216dd2_5d94d4baffe5460d80e3fcbe79c5c1ea.pdf

Posted in Israel's Medical Achievements | Leave a comment